Christopher J. Nardo

Executive Officer at Dermata Therapeutics.

Raised on Dermata Therapeutics filings

$6.7M

of $6.7M offered across 3 Form D filings

Form D filings: 3
Teammates: 10
Last filing: Jan 7, 2026

Company

Dermata Therapeutics

Biotech · San Diego, CA

Treatments for acne, psoriasis and rosacea

Treatments for acne, psoriasis and rosacea

Investors: 7
Founded: 2021

Investors: 7
Sector: Biotech
Founded: 2021
HQ: San Diego, CA

Dermata Therapeutics filings

Dermata Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jan 7, 2026	Equity	$4.1M/ $4.1M	Form D
Feb 4, 2025	Equity	$2.5M/ $2.5M	Form D/A
Jan 28, 2025	Equity	$2.5M/ $2.5M	Form D

EquityFiled Jan 7, 2026Form D
$4.1M/ $4.1M
EquityFiled Feb 4, 2025Form D/A
$2.5M/ $2.5M
EquityFiled Jan 28, 2025Form D
$2.5M/ $2.5M

Works with

Also named on Dermata Therapeutics filings

Gerald ProehlChief Executive Officer, Form D signerForm D signer Steven MentoDirector Kyri K. Van HooseExecutive Officer Maria Bedoya Toro MuneraExecutive Officer Andrew SandlerDirector Brittany BradrickDirector David HaleDirector Kathleen ScottDirector Mary FisherDirector Wendell WierengaDirector